Because baseline water and sanitation access are both likely to affect uptake of the WASH interventions and trial outcomes through multiple pathways, we wanted to optimize balance of these parameters across treatment groups at the start of the trial.
Up to 10 and at least six animals were assigned to each group, and mean tumour volume was standardised across the groups at the start of the experiment: thus the control, PaTrin-2, temozolomide and PaTrin-2 plus temozolomide groups had mean tumour volumes of 29.8±7.6 (range 19.0 38.7), 33.2±14.7 (range 16.5 58.7), 35.1±10.9 (range 20.9 52.4) and 30.3±10.0 (range 20.7 44.5) mm, respectively.
Ten patients continued treatment with a 6- or 8-week EDI and the proportions of patients achieving GH or IGF1 control across dosing-interval groups were similar at the start compared with the end of the study (after 2 3 doses at the assigned injection interval).
Initially, we ran the model across a range of equilibrium group sizes (2 to 12 individuals per group in increments of 2), with the initial equilibrium group size being identical across the grid at the start of each simulation.
The group said sales at the start of the year had been strong, despite the debt crisis and austerity measures across much of Europe, which is H&M's biggest market.
We also looked at this data across the age groups, expecting to see some differences in this order, particularly for those at the start of their career who might have been more motivated to take the job for career reasons.
In the conventional group, time was started at the start of the infusion of cold fluids.
They sledded across a still frozen lake at the start of the season, and canoed across it during the summer months.
Patients in the intervention group received an educational leaflet at the start of the study.
At the start, the other groups of samples are included in this group as well.
Seven randomly selected lambs were slaughtered at the start of the trial (baseline group).
